Plasma Renin Activity Measurement and Clinical Applications

Physiologic Basis

• Plasma renin activity measures the enzymatic activity of renin in converting angiotensinogen to angiotensin I, serving as a functional assessment of the renin-angiotensin-aldosterone system's activity 1, 2
• PRA reflects the functional capacity of the renin-angiotensin system rather than simply the amount of renin protein present, typically reported in ng/mL/hour 1, 3

Clinical Applications

Primary Use: Screening for Primary Aldosteronism

• The American College of Cardiology recommends PRA as the denominator in calculating the aldosterone-to-renin ratio (ARR), which screens for primary aldosteronism 1, 3
• In primary aldosteronism, autonomous aldosterone production suppresses renin secretion, resulting in elevated plasma aldosterone concentration and suppressed PRA 4
• Elevated ARR (>30 when aldosterone is in ng/dL and PRA in ng/mL/h) is indicative of primary aldosteronism 1, 3

Evaluation of Renovascular Hypertension

• The American College of Cardiology suggests that PRA helps assess the renin-angiotensin system's response to renal hypoperfusion 5, 2
• Renal artery stenosis causes elevated PRA due to decreased renal perfusion pressure 5
• The captopril test measures PRA before and 60 minutes after 50 mg oral captopril, with sensitivity of 61% and specificity of 86% for detecting renal artery disease 1, 3
• However, PRA is not recommended as a screening test for renal artery stenosis due to false-negative rates of 43% and false-positive rates of 34% 1, 3

Renal Vein Renin Measurements

• PRA can be measured from renal veins to lateralize renin production 2, 6
• A renal vein renin ratio >1.4:1 with hypertension duration <5 years predicts 95% cure rate after revascularization 1, 2
• However, renal vein renin measurements have been largely supplanted by noninvasive imaging and are now performed infrequently 2, 6

Technical Considerations

Test Methodology

• The enzyme kinetic PRA test using radioimmunoassay has the required sensitivity to detect low renin states 1, 2
• All medications affecting the renin-angiotensin-aldosterone system must be stopped for at least 2 weeks before testing to maximize accuracy 1, 2
• Diuretics increase PRA 1
• Calcium channel blockers and alpha-1 blockers minimally affect ARR and can be continued if stopping all antihypertensives is unsafe 1, 4

Patient Preparation

• Maintain dietary sodium intake of 100-200 mmol/day 1, 2
• Ensure potassium repletion, as hypokalemia suppresses aldosterone production 4
• Collect blood after 2 hours upright and 5-15 minutes seated 4

Interpretation Pitfalls

• Approximately 15% of patients with essential hypertension have elevated PRA, which can cause false-positive results when screening for renovascular disease 1, 3
• Volume expansion, chronic renal failure, bilateral renal artery disease, or disease in a solitary kidney can suppress PRA and cause false-negative results 1, 3
• The specificity of ARR improves when a minimum PRA threshold of 0.5 ng/mL/h is used in calculations, as extremely low renin can artificially elevate the ratio even without truly elevated aldosterone 4